guanethidine has been researched along with prednisolone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anton, AH; Martin, L | 1 |
| Kourounakis, P; Mécs I+MECS, I; Selye, H; Szabo, S; Taché J+TACHE, J; Taché, Y | 1 |
| Dietrich, FM; Komarek, A | 1 |
| Huber, A | 1 |
1 review(s) available for guanethidine and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for guanethidine and prednisolone
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Toxicity of acids and bases after intraperitoneal injection.
Topics: Acetates; Acids; Alkalies; Analgesics; Anesthetics, Local; Animals; Anti-Bacterial Agents; Body Temperature; Chlorpromazine; Cold Temperature; Disease Models, Animal; Ethanol; Guanethidine; Hot Temperature; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Prednisolone; Propylene Glycols; Reserpine; Respiration; Shock, Septic; Tetrabenazine | 1970 |
Effect of glucocorticoids upon resistance to various toxicants.
Topics: Allopurinol; Animals; Antimetabolites; Arsenic; Betamethasone; Cortisone; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Glutethimide; Guanethidine; Hydrazines; Kidney; Medrogestone; Nitriles; Paramethasone; Prednisolone; Prednisone; Rats; Strychnine; Tetraethylammonium Compounds; Time Factors; Triamcinolone; Tubocurarine; Zoxazolamine | 1974 |
Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Bis-Trimethylammonium Compounds; Cortisone; Cyclophosphamide; Dexamethasone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Flumethasone; Freund's Adjuvant; Glucocorticoids; Guanethidine; Guinea Pigs; Hydrocortisone; Lethal Dose 50; Male; Mercaptopurine; Paramethasone; Phenylbutazone; Prednisolone; Prednisone; Rats; Sodium Salicylate; Spinal Cord | 1971 |
[Therapy of oculomotor muscle paralysis].
Topics: Administration, Topical; Anti-Inflammatory Agents; Guanethidine; Humans; Myasthenia Gravis; Myositis; Myotonia Congenita; Myotonic Dystrophy; Neostigmine; Ophthalmic Solutions; Ophthalmoplegia; Prednisolone | 1968 |